InflaRx (IFRX) Non-Current Assets (2016 - 2026)
InflaRx (IFRX) reported Non-Current Assets of $1.76 million for Q2 2026, down 100.0% from $8.23 trillion a year earlier but up 0.6% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Non-Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, InflaRx posted Non-Current Assets of $1.79 million, down 100.0% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $4.66 billion in FY2024 (-100.0%), $11.56 trillion in FY2023, $5.09 million in FY2022 (-84.9%) and $33.7 million in FY2021.
- Five-year quarterly Non-Current Assets spans a low of $1.46 million in Q1 2025 and a high of $11.56 trillion in Q4 2023.
- Year over year, Non-Current Assets gained in two of the last seven quarters, with an average decline of 29.2%.
- The high point for year-over-year Non-Current Assets in five years was Q2 2023 (growth of 745.6%); the low point was Q2 2026 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.75 million (Q1 2026), $1.84 million (Q4 2025) and $1.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | InflaRx | 104.63 Mn | -228.98 Mn | 2.74 Mn | 1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 8.53 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 4.54 Mn |
| Sep 30, 2024 | 6.78 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 4.46 Mn |
| Dec 31, 2023 | 11.89 Mn |
| Sep 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | 22.55 Mn |
| Mar 31, 2023 | 10.80 Mn |
| Dec 31, 2022 | 5.32 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 2.62 Mn |
| Mar 31, 2022 | 12.70 Mn |
| Dec 31, 2021 | 33.36 Mn |
| Sep 30, 2021 | 33.78 Mn |
API Access
InflaRx Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();